Haley L. Zubyk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Haley L. Zubyk has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Andrew G. McArthur
David Braley Centre for Antibiotic Discovery, McMaster University, Hamilton, Ontario, L8S 4K1, Canada
1 shared publication Arman Edalatmand
Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada
1 shared publication- Finlay Maguire
Faculty of Computer Science and Institute for Comparative Genomics, Dalhousie University, Halifax, Nova Scotia, Canada Department of Community Health & Epidemiology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada
1 shared publication - Gerard D. Wright
McMaster University
1 shared publication - Kara K. Tsang
Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK
1 shared publication - Robert G. Beiko
Faculty of Computer Science, Dalhousie University, Halifax, Canada
1 shared publication
Latest Publications
- Open Access
- 1 January 2021
- Published by Microbiology Society in Microbial Genomics
- Vol. 7 (1) , 000500
Identifying novel β-lactamase substrate activity through in silico prediction of antimicrobial resistance
Diagnosing antimicrobial resistance (AMR) in the clinic is based on empirical evidence and current gold standard laboratory phenotypic methods. Genotypic methods have the potential advantages of being faster and cheaper, and having improved mechanistic resolution over phenotypic methods. We generated and applied rule-based and logistic regression models to predict the AMR phenotype from Escherichia coli and Pseudomonas aeruginosa multidrug-resistant clinical isolate genomes. By inspecting and evaluating these models, we identified previously unknown β-lactamase substrate activities. In total, 22 unknown β-lactamase substrate activities were experimentally validated using targeted gene expression studies. Our results demonstrate that generating and analysing predictive models can help guide researchers to the mechanisms driving resistance and improve annotation of AMR genes and phenotypic prediction, and suggest that we cannot solely rely on curated knowledge to predict resistance phenotypes.
- 1 January 2021
- Published by Microbiology Society in Microbial Genomics
- Vol. 7 (1) , 000500
Open AccessIdentifying novel β-lactamase substrate activity through in silico prediction of antimicrobial resistance
Diagnosing antimicrobial resistance (AMR) in the clinic is based on empirical evidence and current gold standard laboratory phenotypic methods. Genotypic methods have the potential advantages of being faster and cheaper, and having improved mechanistic resolution over phenotypic methods. We generated and applied rule-based and logistic regression models to predict the AMR phenotype from Escherichia coli and Pseudomonas aeruginosa multidrug-resistant clinical isolate genomes. By inspecting and evaluating these models, we identified previously unknown β-lactamase substrate activities. In total, 22 unknown β-lactamase substrate activities were experimentally validated using targeted gene expression studies. Our results demonstrate that generating and analysing predictive models can help guide researchers to the mechanisms driving resistance and improve annotation of AMR genes and phenotypic prediction, and suggest that we cannot solely rely on curated knowledge to predict resistance phenotypes.